Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Comment: Sacituzumab govitecan for HR+/HER2‐ advanced breast cancer
Dr Jane Lowe Meisel - Winship Cancer Institute of Emory University, Georgia, USA
Comment: Sacituzumab govitecan for HR+/HER2‐ advanced breast cancer ( Dr Jane Lowe Meisel - Winship Cancer Institute of Emory University, Georgia, USA )
4 Jun 2022
Circulating tumour DNA analysis can help identify the need for adjuvant therapy ...
Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia
Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer ( Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia )
4 Jun 2022
UICC announces global coalition to increase access to essential cancer medicines...
Dr Cary Adams - Chief Executive Officer, UICC
UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries ( Dr Cary Adams - Chief Executive Officer, UICC )
4 Jun 2022
ASCO and WHO to collaborate on quality indicators for cancer facilities
Dr André Ilbawi - Cancer Control Officer, WHO
ASCO and WHO to collaborate on quality indicators for cancer facilities ( Dr André Ilbawi - Cancer Control Officer, WHO )
4 Jun 2022
Sacituzumab govitecan increases PFS for HR+/HER2- metastatic breast cancer
Dr Hope Rugo - University of California San Francisco, San Francisco, USA
Sacituzumab govitecan increases PFS for HR+/HER2- metastatic breast cancer ( Dr Hope Rugo - University of California San Francisco, San Francisco, USA )
4 Jun 2022
Ramucirumab plus pembrolizumab improves OS in advanced NSCLC
Dr Roy Herbst - Yale Cancer Center, New Haven, USA
Ramucirumab plus pembrolizumab improves OS in advanced NSCLC ( Dr Roy Herbst - Yale Cancer Center, New Haven, USA )
4 Jun 2022
Ibrutinib plus chemoimmunotherapy improved PFS for newly diagnosed MCL
Ibrutinib plus chemoimmunotherapy improved PFS for newly diagnosed MCL (  )
3 Jun 2022
Cancer Services Delivery: Focus on India
Dr Soumitra Datta - Tata Medical Center, Kolkata, India
Cancer Services Delivery: Focus on India ( Dr Soumitra Datta - Tata Medical Center, Kolkata, India )
26 May 2022
Understanding India’s compliance to the WHO Framework convention on tobacco cont...
Ms Soumita Ghose - Tata Medical Center, Kolkata, India
Understanding India’s compliance to the WHO Framework convention on tobacco control ( Ms Soumita Ghose - Tata Medical Center, Kolkata, India )
25 May 2022
Pre-operative risk factors associated with peri-operative psychiatric diagnosis ...
Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India
Pre-operative risk factors associated with peri-operative psychiatric diagnosis in oral cancer patients ( Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India )
25 May 2022
Outcomes of clinico-radiologically advanced cancer (cT4b) of buccal mucosa: A re...
Dr Prateek Jain - Tata Medical Center, Kolkata, India
Outcomes of clinico-radiologically advanced cancer (cT4b) of buccal mucosa: A retrospective analysis of 104 patients ( Dr Prateek Jain - Tata Medical Center, Kolkata, India )
25 May 2022
Information sharing experiences of professionals looking after children with can...
Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India
Information sharing experiences of professionals looking after children with cancer ( Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India )
25 May 2022